» Articles » PMID: 15222652

Metabolic Syndrome: Time for Action

Overview
Specialty Public Health
Date 2004 Jun 30
PMID 15222652
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The constellation of dyslipidemia (hypertriglyceridemia and low levels of high-density lipoprotein cholesterol), elevated blood pressure, impaired glucose tolerance, and central obesity is identified now as metabolic syndrome, also called syndrome X. Soon, metabolic syndrome will overtake cigarette smoking as the number one risk factor for heart disease among the U.S. population. The National Cholesterol Education Program-Adult Treatment Panel III has identified metabolic syndrome as an indication for vigorous lifestyle intervention. Effective interventions include diet, exercise, and judicious use of pharmacologic agents to address specific risk factors. Weight loss significantly improves all aspects of metabolic syndrome. Increasing physical activity and decreasing caloric intake by reducing portion sizes will improve metabolic syndrome abnormalities, even in the absence of weight loss. Specific dietary changes that are appropriate for addressing different aspects of the syndrome include reducing saturated fat intake to lower insulin resistance, reducing sodium intake to lower blood pressure, and reducing high-glycemic-index carbohydrate intake to lower triglyceride levels. A diet that includes more fruits, vegetables, whole grains, monounsaturated fats, and low-fat dairy products will benefit most patients with metabolic syndrome. Family physicians can be more effective in helping patients to change their lifestyle behaviors by assessing each patient for the presence of specific risk factors, clearly communicating these risk factors to patients, identifying appropriate interventions to address specific risks, and assisting patients in identifying barriers to behavior change.

Citing Articles

Visseral Lipectomy Improves Metabolic Syndrome Parameters and Adipokines in a Rat Model of Metabolic Syndrome Induced by Monosodium Glutamate.

Tunc-Ata M, Altunay Z, Senol H, Kucukatay V Aesthetic Plast Surg. 2024; .

PMID: 39542896 DOI: 10.1007/s00266-024-04486-0.


Caffeine: a potential mechanism for anti-obesity.

Wang M, Guo W, Chen J Purinergic Signal. 2024; .

PMID: 38802651 DOI: 10.1007/s11302-024-10022-1.


Association between Metabolic Syndrome Risk Factors and Immunohistochemical Profile in Women with Breast Cancer.

Danesh H, Anbiaei R, Ziamajidi N, Farhadian M, Barartabar Z, Abbasalipourkabir R Iran J Med Sci. 2023; 48(5):456-464.

PMID: 37786471 PMC: 10541543. DOI: 10.30476/IJMS.2022.95039.2673.


Nanoformulations of natural products for management of metabolic syndrome.

Taghipour Y, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A Int J Nanomedicine. 2019; 14:5303-5321.

PMID: 31406461 PMC: 6642644. DOI: 10.2147/IJN.S213831.


Preliminary assessment of Neck Circumference in Benign Prostatic Hyperplasia in Patients with Metabolic Syndrome.

Akin Y, Gulmez H, Ates E, Gulum M, Savas M Int Braz J Urol. 2017; 43(1):95-103.

PMID: 28124531 PMC: 5293389. DOI: 10.1590/S1677-5538.IBJU.2016.0139.